Glucagon

胰高血糖素

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameGlucagon
Drug Alias NameGlucagonum胰增血糖素Glucagon for Injection (rDNA origin)胰高糖素升血糖素 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonists
TargetsGlucagon receptor
Therapy Area/IndicationsHypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsHypoglycemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/11/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesTetris Pharma LtdDuke University
Inactive CompaniesEli Lilly And CompanyAbvance Therapeutics
Active IndicationsDiabetes Mellitus
Inactive IndicationsHypoglycemiaDiabetes Mellitus, Type 1

Other Information

ATC CodeH04AA01
Related LinksWikipediaDrugBankKEGG